| Authors: |
Garside H; ApconiX Ltd. Alderley Park, Macclesfield, UK., Aslamkhan A; Nonclinical Drug Safety, Merck & Co., Inc., West Point, PA, USA., Daniels DL; Foghorn Therapeutics, Cambridge, MA, USA., Datta K; Nonclinical Safety, Bristol Myers Squibb, New Brunswick, NJ, USA.; Nonclinical Drug Safety, Merck & Co., Inc., West Point, PA, USA., Egebjerg M; Safety Pharmacology & Early Toxicology, Novo Nordisk A/S, Måløv, Denmark., Hukkanen RR; Translational Safety & Risk Sciences, Amgen Research, Amgen Inc, Cambridge, MA, USA., Jones LH; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Ketter N; Non-clinical Safety Science, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Lahoti TS; Drug Safety Research & Evaluation, Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Development Sciences, Atrium Therapeutics, San Diego, CA, USA., Loberg LI; Emerging Therapeutic Platforms, AbbVie, Inc., North Chicago, IL, USA., Messmer D; Nurix Therapeutics, San Francisco, CA, USA., O'Lone R; Health & Environmental Sciences Institute (HESI), Washington, DC, USA., Pastoor T; Oerth Bio, Durham, NC, USA., Pavkovic M; Preclinical Development, Pharma R&D, Bayer AG, Wuppertal, Germany., Pereira Mouriès L; Health & Environmental Sciences Institute (HESI), Washington, DC, USA., Rankovic Z; Institute of Cancer Research, London, Sutton, UK., Rengarajan A; Nonclinical Drug Safety, Merck & Co., Inc., West Point, PA, USA., Vargesson N; Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Foresterhill, Aberdeen, UK., Vicart A; Preclinical Safety, Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Wange RL; Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.; Aclairo Pharmaceutical, Development Group, Inc., Sterling, VA, USA., Yanochko-Hoffman G; Preclinical Sciences & Translational Safety, Johnson & Johnson, San Diego, CA, USA., Roberts R; ApconiX Ltd. Alderley Park, Macclesfield, UK. ruth.roberts@apconix.com.; School of Biosciences, University of Birmingham, Edgbaston, UK. ruth.roberts@apconix.com., Sidaway J; ApconiX Ltd. Alderley Park, Macclesfield, UK. |
